ASML vs CDTX · P/E 57, $665.37B cap vs rev $1.3M
ASML Holding NV ADR (ASML) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the ASML and CDTX stock pages for the full models.
Not investment advice.